Therapy of Relapsed Hodgkin Lymphoma

This publication has 64 references indexed in Scilit:

• Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma
  Blood, 2006
• Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol
  Transplantation and Cellular Therapy, 2006
• Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma
  Journal of Clinical Oncology, 2005
• Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen
  Bone Marrow Transplantation, 2005
• Salvage Radiotherapy in Patients With Relapsed and Refractory Hodgkin’s Lymphoma: A Retrospective Analysis From the German Hodgkin Lymphoma Study Group
  Journal of Clinical Oncology, 2005
• HLA-matched related (MRD) or unrelated donor (URD) nonmyeloablative conditioning and hematopoietic cell transplant (HCT) for patients with advanced Hodgkin disease (HD)
  Transplantation and Cellular Therapy, 2004
• Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen
  Bone Marrow Transplantation, 2003
• New Prognostic Score Based on Treatment Outcome of Patients With Relapsed Hodgkin's Lymphoma Registered in the Database of the German Hodgkin's Lymphoma Study Group
  Journal of Clinical Oncology, 2002
• A Prognostic Score for Advanced Hodgkin's Disease
  New England Journal of Medicine, 1998
• Etoposide (VP-16–213)
  New England Journal of Medicine, 1985